This inventor holds 2 USPTO granted patents. Top assignee: Memory Pharmaceuticals Corporation. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: True Minh Nguyen: Innovator in Nicotinic Acetylcholine Receptor Research
Introduction
True Minh Nguyen is a notable inventor based in New York, NY (US). He has made significant contributions to the field of pharmacology, particularly in the development of ligands for nicotinic acetylcholine receptors. With a total of two patents to his name, Nguyen's work focuses on addressing disease conditions associated with malfunctioning nicotinic acetylcholine receptors, especially in the brain.
Latest Patents
Nguyen's latest patents involve the synthesis and application of various compounds, including indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, and isothiazolopyridines. These inventions relate to the activation of nicotinic acetylcholine receptors (nACh receptors) and their potential therapeutic uses. The patents detail methods for preparing these novel compounds, which act as ligands for the α7 nACh receptor subtype, and outline their compositions and methods of use.
Career Highlights
True Minh Nguyen is associated with Memory Pharmaceuticals Corporation, where he has been instrumental in advancing research on nicotinic acetylcholine receptors. His innovative approach has contributed to the understanding of how these receptors function and their role in various neurological conditions.
Collaborations
Nguyen has collaborated with notable colleagues, including Richard A Schumacher and Mihaela Diana Danca, who have supported his research endeavors. Their combined expertise has furthered the exploration of ligands for nACh receptors.
Conclusion
True Minh Nguyen's work exemplifies the intersection of innovation and medical research, particularly in the realm of nicotinic acetylcholine receptors. His patents and collaborations highlight his commitment to advancing therapeutic solutions for neurological disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
